250 related articles for article (PubMed ID: 31632120)
1. Current Insights Into The Management Of Discoid Lupus Erythematosus.
Company-Quiroga J; Alique-García S; Romero-Maté A
Clin Cosmet Investig Dermatol; 2019; 12():721-732. PubMed ID: 31632120
[TBL] [Abstract][Full Text] [Related]
2. Review of treatment for discoid lupus erythematosus.
Garza-Mayers AC; McClurkin M; Smith GP
Dermatol Ther; 2016 Jul; 29(4):274-83. PubMed ID: 27073142
[TBL] [Abstract][Full Text] [Related]
3. Cutaneous lupus erythematosus: issues in diagnosis and treatment.
Walling HW; Sontheimer RD
Am J Clin Dermatol; 2009; 10(6):365-81. PubMed ID: 19824738
[TBL] [Abstract][Full Text] [Related]
4. Topical calcineurin inhibitors in systemic lupus erythematosus.
Lampropoulos CE; D'Cruz DP
Ther Clin Risk Manag; 2010 Apr; 6():95-101. PubMed ID: 20421909
[TBL] [Abstract][Full Text] [Related]
5. Innovative management of lupus erythematosus.
Knott HM; Martínez JD
Dermatol Clin; 2010 Jul; 28(3):489-99. PubMed ID: 20510759
[TBL] [Abstract][Full Text] [Related]
6. Cutaneous lupus erythematosus: a personal approach to management.
Callen JP
Australas J Dermatol; 2006 Feb; 47(1):13-27. PubMed ID: 16405478
[TBL] [Abstract][Full Text] [Related]
7. Drugs for discoid lupus erythematosus.
Jessop S; Whitelaw DA; Delamere FM
Cochrane Database Syst Rev; 2009 Oct; (4):CD002954. PubMed ID: 19821298
[TBL] [Abstract][Full Text] [Related]
8. Linear discoid lupus erythematosus mimicking
Hassan M; Watters KA; Netchiporouk E
SAGE Open Med Case Rep; 2019; 7():2050313X19882843. PubMed ID: 31666954
[TBL] [Abstract][Full Text] [Related]
9. Topical tacrolimus and pimecrolimus in the treatment of cutaneous lupus erythematosus: an evidence-based evaluation.
Tzellos TG; Kouvelas D
Eur J Clin Pharmacol; 2008 Apr; 64(4):337-41. PubMed ID: 18157526
[TBL] [Abstract][Full Text] [Related]
10. [Discoid lupus erythematosus with eyelid involvement. A series of nine patients].
Mseddi M; Marrekchi S; Meziou TJ; Sellami D; Kammoun B; Feki J; Zahaf A; Turki H
J Fr Ophtalmol; 2007 Mar; 30(3):247-9. PubMed ID: 17417149
[TBL] [Abstract][Full Text] [Related]
11. Intravenous Immunoglobulin in the Management of Lupus Erythematosus Panniculitis.
AlQadri NG; AlNooh B; AlTewerki MM; Almotairi A; Alajlan S
Cureus; 2020 Jan; 12(1):e6790. PubMed ID: 32025447
[TBL] [Abstract][Full Text] [Related]
12. Intravenous Immunoglobulins as a new opportunity to treat discoid lupus erythematosus: A case report and review of the literature.
Tenti S; Fabbroni M; Mancini V; Russo F; Galeazzi M; Fioravanti A
Autoimmun Rev; 2018 Aug; 17(8):791-795. PubMed ID: 29885539
[TBL] [Abstract][Full Text] [Related]
13. An update on the management of refractory cutaneous lupus erythematosus.
Verdelli A; Corrà A; Mariotti EB; Aimo C; Ruffo di Calabria V; Volpi W; Quintarelli L; Caproni M
Front Med (Lausanne); 2022; 9():941003. PubMed ID: 36213629
[TBL] [Abstract][Full Text] [Related]
14. Treatment of Cutaneous Lupus Erythematosus: Review and Assessment of Treatment Benefits Based on Oxford Centre for Evidence-based Medicine Criteria.
Winkelmann RR; Kim GK; Del Rosso JQ
J Clin Aesthet Dermatol; 2013 Jan; 6(1):27-38. PubMed ID: 23320123
[TBL] [Abstract][Full Text] [Related]
15. Management of "refractory" skin disease in patients with lupus erythematosus.
Callen JP
Best Pract Res Clin Rheumatol; 2005 Oct; 19(5):767-84. PubMed ID: 16150402
[TBL] [Abstract][Full Text] [Related]
16. Drugs for discoid lupus erythematosus.
Jessop S; Whitelaw D; Jordaan F
Cochrane Database Syst Rev; 2001; (1):CD002954. PubMed ID: 11279785
[TBL] [Abstract][Full Text] [Related]
17. Combined mepacrine-hydroxychloroquine treatment in patients with systemic lupus erythematosus and refractory cutaneous and articular activity.
Ugarte A; Porta S; Ríos R; Martinez-Zapico A; Ortego-Centeno N; Agesta N; Ruiz-Irastorza G
Lupus; 2018 Sep; 27(10):1718-1722. PubMed ID: 29635998
[TBL] [Abstract][Full Text] [Related]
18. Is chronic cutaneous discoid lupus protective against severe renal disease in patients with systemic lupus erythematosus?
Merola JF; Chang CA; Sanchez MR; Prystowsky SD
J Drugs Dermatol; 2011 Dec; 10(12):1413-20. PubMed ID: 22134565
[TBL] [Abstract][Full Text] [Related]
19. Patients with cutaneous lupus erythematosus who smoke are less responsive to antimalarial treatment.
Jewell ML; McCauliffe DP
J Am Acad Dermatol; 2000 Jun; 42(6):983-7. PubMed ID: 10827400
[TBL] [Abstract][Full Text] [Related]
20. Hardness and Painful Lesion of the Breast.
Vilas-Sueiro A; González-Vilas D; Aguilera C; Monteagudo B; De Las Heras C
Acta Dermatovenerol Croat; 2017 Dec; 25(4):305-306. PubMed ID: 30064607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
